Search results
Added:
2 weeks ago
American College of Cardiology Congress 2026 – Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the effects of tirzepatide compared with dulaglutide on expanded cardiorenal outcomes from the SURPASS-CVOT trial (NCT04255433; Eli Lilly and Company).This international, double-blind, randomised, phase III cardiovascular outcomes trial enrolled 13,299 patients aged 40 and…
View more
Added:
1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each…
View more
Added:
1 year ago
Unpack ACC.25's Top Trials with View from the Thoraxcenter!Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC 2025.In this thought-provoking ACC 2025 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current practice and future research directions.00:36 -…
View more
Added:
1 year ago
AHA Conference 2024 - In this highlights video from AHA 2024, Dr Michelle Kittleson (Cedars-Sinai California Heart Center, US) offers a concise and insightful summary of the most influential late-breaking trials presented at the conference. Dr Kittleson discusses the pivotal studies poised to impact clinical practice and enhance patient outcomes in heart failure care.Trials covered in detail…
View more
Added:
10 months ago
Guest Editor Dr Vijay Chopra discusses the motivation behind the newly curated Special Focus on mineralocorticoid receptor antagonists.Dr Chopra explores why this topic is more relevant than ever, particularly as the field moves beyond traditional aldosterone antagonists toward novel agents like finerenone and aldosterone synthase inhibitors.From addressing hyperkalaemia fears to identifying gaps…
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Paul Stevens discusses 2024 KDIGO guideline updates.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Muthiah Vaduganathan and Dr David Charytan discuss the practical implementation of non-steroidal mineralocorticoid receptor antagonists to reduce cardiorenal risk.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Vijay Chopra, Dr Deepak Bhatt, Dr Michelle Wong and Dr George L Bakris discuss early intervention and intensive management for CRM disease.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Scott Isaacs, Prof Peter Rossing, Dr Muthiah Vaduganathan, Prof Stefan Anker and Dr Javed Butler discuss weight management for CRM disease.
View more
Added:
1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Gerasimos Filippatos, Dr Manisha Sahay, Prof Gianluigi Savarese, Prof Francesco Cosentino and Prof Sam Seidu discuss multidisciplinary implementation strategies.
View more